Dureshahwar khan

pharmacoeconomics pharmacovigilance adr outcomes research pharmaceutical care healthcare electronic medical records e records healthcare ecosystem clinical trials phases of clinical trials preclinical studies advantages and disadvantages traditional development program value added development program development programs pharmacoeconomics evaluation perspectives of pharmacoeconomics cdsco pvpi history of pharmacovigilance safety monitoring who who in pharmacovigilance role & responsibilities of pv health economics health care concepts in health economics effeciency equity utility cost benefit marginal economic analysis cost-effectiveness analysis (cea) cost-utility analysis (cua) cost-benefit analysis (cba) three dimensional analysis echo economic outcome clinical outcome humanistic outcome vaccine pharmacovigilance aefi adr reporting reporting process adr reporting form pharmacovigalance tools in pharmacovigilance adverse events softwares in pharmacovigilance oracle argus safety arisg oracle aers clintrace pvnet repclinical webvdme pharmacovigilance pv works pv pv in hospitals case report form new paradigms vigibase pv program in india medication safety who pidm upsala monitoring centre umc who art meddra cioms ich e2d guidelines icd passive surveillance active surveillance observational studies who-fic inn cohort studies case control study cross sectional study pv in industry